These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 310826)

  • 1. Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):175-81. PubMed ID: 310826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
    Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB
    J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.
    Kawase I; Brooks CG; Kuribayashi K; Olabuenaga S; Newman W; Gillis S; Henney CS
    J Immunol; 1983 Jul; 131(1):288-92. PubMed ID: 6408175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of the cell surface properties of activated vs endogenous mouse natural killer cells.
    Kiessling R; Eriksson E; Hallenbeck LA; Welsh RM
    J Immunol; 1980 Oct; 125(4):1551-7. PubMed ID: 6157740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):182-8. PubMed ID: 216746
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of natural killer cell activity and interferon production by manganese in young mice.
    Smialowicz RJ; Riddle MM; Rogers RR; Luebke RW; Burleson GR
    Immunopharmacol Immunotoxicol; 1988; 10(1):93-107. PubMed ID: 2452180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
    Kaminsky SG; Nakamura I; Cudkowicz G
    J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E; Savary CA; Stringfellow DA
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renewal of natural killer cells in mice having elevated natural killer cell activity.
    Nassiry L; Miller SC
    Nat Immun Cell Growth Regul; 1987; 6(5):250-9. PubMed ID: 3444438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E; Gunji Y; Herberman RB
    J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
    Salazar-Mather TP; Ishikawa R; Biron CA
    J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
    Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
    Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.